GHENT, Belgium, July 13, 2021 /PRNewswire/ -- ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that it has generated data on its COVID-19 antibody XVR011 which demonstrate in vitro neutralization activity...
from PR Newswire: https://ift.tt/3eeh4PH
No comments:
Post a Comment